Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group (Q59616739)
Jump to navigation
Jump to search
scientific article published on 23 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group |
scientific article published on 23 January 2012 |
Statements
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group (English)
Raimund Jakesz
Peter C Dubsky
Brigitte Mlineritsch
Gero Luschin-Ebengreuth
Sabine Pöstlberger
Günther G Steger
Werner Kwasny
Michael Stierer
Margaretha Rudas
Rupert Bartsch
Susanne Taucher
Lidija Filipcic
Christian F Singer
Hellmut Samonigg
Christoph Tausch
Herbert Stöger
Karin Haider
Paul Sevelda
23 January 2012